更多的开放性和少一点炫耀：这是关于支架及其植入者的两个好主意。 - Suppr

Suppr

超能文献

More openness and a little less strut: two good ideas for stents and the people who implant them.

作者信息

Morrison Douglass A

出版信息

Catheter Cardiovasc Interv. 2010 Nov 1;76(5):652-3. doi: 10.1002/ccd.22832.

DOI:10.1002/ccd.22832

PMID:20976746

Abstract

摘要

相似文献

More openness and a little less strut: two good ideas for stents and the people who implant them.

Catheter Cardiovasc Interv. 2010 Nov 1;76(5):652-3. doi: 10.1002/ccd.22832.

Another small step for small vessels.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):67-9. doi: 10.1002/ccd.22686.

Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):13-4. doi: 10.1002/ccd.22919.

The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):1076-7; author reply 1078. doi: 10.1002/ccd.22715.

If I've heard it once, I've heard it (not yet) a hundred times.

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):502. doi: 10.1002/ccd.22989.

It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):949-50. doi: 10.1002/ccd.22892.

Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):58-9. doi: 10.1002/ccd.22678.

Stenting unprotected left main: the outcome is not always favorable.

Catheter Cardiovasc Interv. 2008 Mar 1;71(4):539-40. doi: 10.1002/ccd.21536.

Left main and high-risk PCI: what, exactly, is it high risk for?

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):952-3. doi: 10.1002/ccd.23208.

Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.

JACC Cardiovasc Interv. 2008 Apr;1(2):136-8. doi: 10.1016/j.jcin.2008.02.006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

More openness and a little less strut: two good ideas for stents and the people who implant them.

Catheter Cardiovasc Interv. 2010 Nov 1;76(5):652-3. doi: 10.1002/ccd.22832.

Another small step for small vessels.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):67-9. doi: 10.1002/ccd.22686.

Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):13-4. doi: 10.1002/ccd.22919.

The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):1076-7; author reply 1078. doi: 10.1002/ccd.22715.

If I've heard it once, I've heard it (not yet) a hundred times.

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):502. doi: 10.1002/ccd.22989.

It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?

Catheter Cardiovasc Interv. 2010 Dec 1;76(7):949-50. doi: 10.1002/ccd.22892.

Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):58-9. doi: 10.1002/ccd.22678.

Stenting unprotected left main: the outcome is not always favorable.

Catheter Cardiovasc Interv. 2008 Mar 1;71(4):539-40. doi: 10.1002/ccd.21536.

Left main and high-risk PCI: what, exactly, is it high risk for?

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):952-3. doi: 10.1002/ccd.23208.

Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.

JACC Cardiovasc Interv. 2008 Apr;1(2):136-8. doi: 10.1016/j.jcin.2008.02.006.